DIRECTOR, MTBI2
BRADLEY A. DENGLER, MD, FAANS, FACS
LIEUTENANT COLONEL, MEDICAL CORPS, UNITED STATES ARMY
Dr. Bradley A. Dengler is Director of the Military Traumatic Brain Injury Initiative (MTBI2). As such, Dr. Dengler oversees our robust, interdisciplinary traumatic brain injury (TBI) research portfolio and leads its strategic vision to improve the long-term outcomes of U.S. service members with TBI.
Dr. Dengler currently serves as the Neurosurgery Consultant to the Army Surgeon General. In addition to serving as the director of MTBI2, he is the Director of Neurotrauma/Neurocritical Care in the Division of Neurosurgery at the Walter Reed National Military Medical Center (WRNMMC), and the Program Director of Neurological Surgery Residency for the National Capital Consortium.
Dr. Dengler specializes in neurocritical care, with a particular focus on treating patients with severe TBI. He is passionate about finding new and more objective measures for diagnosing TBIs, in order to better predict return-to-duty in service members with mild brain injuries, as well as methods to improve far-forward TBI battlefield care.
He graduated from the United States Military Academy at West Point and earned his Doctor of Medicine from the Uniformed Services University of the Health Sciences’ F. Edward Hébert School of Medicine. Dr. Dengler completed his Neurosurgery Residency and Neurocritical Care Fellowship at University of Texas Health Science Center at San Antonio.
Dr. Dengler also has significant operational experience, having served as Brigade Surgeon for the 41st Fires Brigade at Fort Cavasos TX, and as Chief of Neurosurgery for Task Force Med 10 and Task Force Med 14 in Iraq during deployments in 2018 and 2019-2020.
Learn more about Dr. Dengler through his bio.